Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Nicola Latronico and Franco Franceschini.
Nicola Latronico
Connection Strength
0.276
Franco Franceschini
  1. Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy. Autoimmun Rev. 2020 Jul; 19(7):102568.
    View in: PubMed
    Score: 0.220
  2. Laboratory considerations amidst the coronavirus disease 2019 outbreak: the Spedali Civili in Brescia experience. Bioanalysis. 2020 Sep; 12(17):1223-1230.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.